Ftse Mib
34.165,92
0,01%
DAX
19.909,14
-0,25%
S&P 500
5.929,22
-0,70%
NASDAQ
19.560,69
-0,82%
Bitcoin
93.046,86
-0,51%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Telomir Pharmaceuticals Inc (TELO) Telomir Pharmaceuticals Inc (TELO) Notizie

Telomir Pharmaceuticals Inc

TELO
4,56
-0,31 (-6,37%)
Ultimo aggiornamento: 18:22:19
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
23/12/202413:00EDGAR2Form 8-K - Current report
20/12/202423:00EDGAR2Form 8-K - Current report
11/12/202422:01EDGAR2Form 8-K - Current report
02/12/202422:01EDGAR2Form 8-K - Current report
25/11/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202422:15EDGAR2Form 8-K - Current report
20/11/202422:15EDGAR2Form 8-K - Current report
12/11/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/9/202422:15EDGAR2Form 8-K - Current report
12/8/202414:30GLOBETelomir Pharmaceuticals Mourns the Passing of Chairman and..
02/7/202414:30GLOBETelomir Pharmaceuticals Added to Membership of Russell 3000..
17/6/202422:10GLOBETelomir Pharmaceuticals Scientific Advisor to Participate in..
30/5/202414:30GLOBETelomir Pharmaceuticals Announces Two Pivotal Milestones for..
24/5/202415:30GLOBENew to The Street TV Announces Episode 575 with its Four..
16/5/202415:30GLOBETelomir Pharmaceuticals, Inc. Signs Media Deal with New to..
13/5/202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16/4/202414:30GLOBETelomir Pharmaceuticals Unveils Compelling Pre-clinical Data..
02/4/202414:30GLOBETelomir Pharmaceuticals’ Anti-Aging Expert and NYT..
29/3/202421:44GLOBEUPDATE – Telomir Pharmaceuticals Announces Collaboration..
26/3/202413:30GLOBETelomir Pharmaceuticals Announces Collaboration with Argenta..
22/3/202413:30GLOBETelomir Pharmaceuticals Releases New Pre-Clinical Data for..
14/3/202413:30GLOBETelomir Pharmaceuticals Uses AI Testing Models to Show its..
07/3/202414:30GLOBETelomir Pharmaceuticals Presents Promising Pre-Clinical Data..
05/3/202414:30GLOBEMichael F. Roizen, MD to Increase Activities with Telomir..
13/2/202422:05GLOBETelomir Pharmaceuticals Announces Closing of Initial Public..
Apertura: 4,80 Min: 4,52 Max: 4,82
Chiusura: 4,87

La tua Cronologia

NASDAQ
TELO
Telomir Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network